We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Screen-Detected Breast Cancers Are Mostly Invasive

By HospiMedica International staff writers
Posted on 26 Sep 2023

Annual breast MRI screening is advised for patients with a lifetime breast cancer risk exceeding 20%. More...

There exists robust data about the features of mammographic screen-detected breast cancers, although there is less information about MRI-screen-detected cancers. Now, new research has found that MRI screen-detected breast cancers are most often invasive.

A team of researchers at Johns Hopkins University (Baltimore, MD, USA) has discovered that invasive cancers detected by MRI usually appear as a mass. They also noted that ductal carcinoma in situ (DCIS), a non-invasive cancer, tends to show up as non-mass enhancement. The study involved analyzing the clinical results and imaging characteristics of 50 breast cancers found in 47 women through MRI screening from 2016 to 2022.

The researchers found that of the 50 MRI-detected breast cancers in these 47 women, a significant number were invasive, accounting for 64% of the cases. The vast majority of patients, 91%, were diagnosed with stage 0 or 1 disease. Regarding how these cancers appeared on MRI, 50% were seen as masses, 48% showed up as non-mass enhancement, and the remaining 2% were identified as a focus. The study confirmed that cancers found through MRI screening are mainly invasive but also highlighted that these cancers generally have an excellent prognosis based on the study sample. The most common form of invasive cancer appeared as a mass. These insights could help medical professionals better interpret MRI results and improve the diagnostic accuracy of these screenings.

Related Links:
Johns Hopkins University


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Monitor/Defibrillator
Zenix
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.